NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / India set to start COVID-19 vaccination; panel approves Oxford vaccine
    India

    India set to start COVID-19 vaccination; panel approves Oxford vaccine

    India set to start COVID-19 vaccination; panel approves Oxford vaccine
    Written by Shalini Ojha
    Jan 01, 2021, 05:57 pm 3 min read
    India set to start COVID-19 vaccination; panel approves Oxford vaccine

    In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca. Now, the vaccine is awaiting a green signal from the Drugs Controller General of India, Dr. VG Somani. Once that is given, the inoculation process will begin. Here's more.

    Panel met today to evaluate SII and Bharat Biotech's applications

    The panel met today — the first day of 2021 — to judge pleas filed by Serum Institute of India (SII), which partnered with Oxford to produce millions of doses of the vaccine, and Bharat Biotech, which is developing COVAXIN. US-based Pfizer's application was also taken up. The chances of SII looked bright after the Oxford vaccine was approved by the United Kingdom administration.

    SII's vaccine will not cost more than Rs. 1,000

    The vaccine, dubbed Covishield in India, will cost somewhere between Rs. 700 and Rs. 800 for the private market, SII's CEO Adar Poonawalla had said earlier. Though SII has reportedly already produced 50 million doses of the vaccine, it will concentrate on fulfilling the home market's demands before turning the focus on export. India plans to vaccinate 30 crore people in the next six-eight months.

    The two-dose vaccine was found to be 70% effective

    The vaccine consists of the replication-deficient chimpanzee viral vector (ChAdOx1) based on a weakened version of a common cold virus (adenovirus) containing the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the spike protein produced triggers an immune response that offers protection against future SARS-CoV-2 infections. The two-dose vaccine has been found to have an average efficacy of 70%.

    Panel had met on Wednesday as well, analyzed data

    The last time the expert panel met was on Wednesday and concluded that some documents were missing, which SII had to update. "Further time was requested on behalf of Pfizer. The additional data and information presented by SII and Bharat Biotech Pvt. Ltd. were perused and analyzed by the SEC. The analysis of additional data and information is going on," a statement revealed earlier.

    A dry run will begin tomorrow across the nation

    Earlier, Dr. Somani had indicated that India will approve a vaccine in the new year. "Probably, we will have a happy New Year with something in hand. That is what I can hint at," he said on Thursday. The approval of the vaccine came a day before states are slated to begin a dry run for the vaccination. The first dry run was successful.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Oxford
    United Kingdom
    University of Oxford
    Central Drugs Standard Control Organization (CDSCO)

    Latest

    Happy Birthday, Abhishek Bachchan: 5 award-winning roles of 'Dasvi' actor Abhishek Bachchan
    Celebrate World Nutella Day in flavor with these easy-breezy recipes Food
    Why Pixel 7 Pro is better than Samsung S23 Ultra Samsung Galaxy S23 Ultra
    Hair transplant: Types, risks, side effects, and recovery Health & Wellness

    Oxford

    Cambridge Dictionary alters 'man' and 'woman' definitions, faces criticism Social Media
    Coronavirus vaccine consignment awaits government nod for take-off from Pune West Bengal
    All states to hold dry run for coronavirus vaccination today India
    Coronavirus: India's daily death toll remained under 300 last week India

    United Kingdom

    Meet actor Dalljiet Kaur's fiance Nikhil Patel; wedding details inside Celebrity
    Australia to replace Queen Elizabeth II's image on $5 banknote Australia
    Putin threatened with missile strike before Russia-Ukraine war: Boris Johnson Boris Johnson
    UK: PM Rishi Sunak fined for not wearing seatbelt; apologizes Rishi Sunak

    University of Oxford

    COVID-19 increases risk of brain fog, dementia: Study COVID-19
    Oxford University testing COVID-19 vaccine in children Coronavirus
    Over 10 lakh inoculated, India's vaccination drive picks pace India
    Centre will sponsor vaccination of healthcare, frontline workers: PM Modi Narendra Modi

    Central Drugs Standard Control Organization (CDSCO)

    Centre refutes reports on side-effects of COVID-19 vaccines Union Health Ministry
    Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs Bharat Biotech
    COVID-19: Centre approves Bharat Biotech's nasal vaccine as booster dose Vaccine
    Haryana government halts cough syrup production linked to Gambia deaths World Health Organization

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023